Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis
- PMID: 28956816
- PMCID: PMC5691691
- DOI: 10.3390/nu9101074
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis
Abstract
There are very few reports about the intake of nutrients for the development or progression of non-alcoholic steatohepatitis (NASH). The aim of this study was to identify the dietary habits and the nutrient intake in patients with NASH, in comparison to chronic hepatitis C (HCV)-related patients. We prospectively evaluated the intake of macronutrients and micronutrients in 124 NAFLD and 162 HCV patients, compared to 2326 subjects as a control group. We noticed major differences in macro- and micronutrients intakes in NASH and HCV patients compared to controls. Proteins, carbohydrate (glucose, fructose, sucrose, maltose and amide), saturated fatty acid (SFA), monounsaturated fatty acid (MUFA), folic acid, vitamin A and C (p < 0.0001), and thiamine (p < 0.0003) ingestion was found to be higher in patients with NASH, while total lipids, polyunsaturated fatty acid (PUFA), riboflavin and vitamin B6 daily intake were lower compared to controls (p < 0.0001). Similarly, NASH patients had significantly reduced carbohydrate intake (p < 0.0001) and an increased intake of calcium (p < 0.0001) compared to HCV positive patients. Finally, we showed in NASH males an increase in the intake of SFA, PUFA, soluble carbohydrates (p < 0.0001) and a decrease in the amount of fiber (p < 0.0001) compared to control males. In NASH female population, we showed an increase of daily total calories, SFA, MUFA, soluble carbohydrates, starch and vitamin D ingested (p < 0.0001) with a reduction of fibers and calcium (p < 0.0001) compared to control females. This study showed how NASH patients' diets, in both male and females, is affected by a profound alteration in macro- and micronutrients intake.
Keywords: dietary intake; macronutrients; micronutrients; non-alcoholic steatohepatitis.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls.J Acad Nutr Diet. 2014 Aug;114(8):1181-94. doi: 10.1016/j.jand.2014.01.009. Epub 2014 Mar 14. J Acad Nutr Diet. 2014. PMID: 24631112
-
Dietary habits and nutrient intake in non-alcoholic steatohepatitis.Nutrition. 2007 Jan;23(1):46-52. doi: 10.1016/j.nut.2006.09.004. Epub 2006 Nov 29. Nutrition. 2007. PMID: 17140767
-
Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH).Eur Rev Med Pharmacol Sci. 2005 Sep-Oct;9(5):265-8. Eur Rev Med Pharmacol Sci. 2005. PMID: 16231587
-
Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.Nutrients. 2017 Sep 26;9(10):1065. doi: 10.3390/nu9101065. Nutrients. 2017. PMID: 28954437 Free PMC article. Review.
-
Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance.Nutrients. 2015 Nov 5;7(11):9127-38. doi: 10.3390/nu7115454. Nutrients. 2015. PMID: 26556368 Free PMC article. Review.
Cited by
-
Association between dietary vitamin A intake from different sources and non-alcoholic fatty liver disease among adults.Sci Rep. 2024 Jan 22;14(1):1851. doi: 10.1038/s41598-024-52077-5. Sci Rep. 2024. PMID: 38253816 Free PMC article.
-
Fatty acid composition but not quantity is an important indicator of non-alcoholic fatty liver disease: a systematic review.Eur J Clin Nutr. 2023 Dec;77(12):1113-1129. doi: 10.1038/s41430-023-01335-2. Epub 2023 Sep 4. Eur J Clin Nutr. 2023. PMID: 37661229
-
Efficacy and safety of omega-3 fatty acids on liver-related outcomes in patients with nonalcoholic fatty liver disease: A protocol for a systematic review and meta-analysis.Medicine (Baltimore). 2020 Jun 12;99(24):e20624. doi: 10.1097/MD.0000000000020624. Medicine (Baltimore). 2020. PMID: 32541499 Free PMC article.
-
Effects of riboflavin deficiency and high dietary fat on hepatic lipid accumulation: a synergetic action in the development of non-alcoholic fatty liver disease.Nutr Metab (Lond). 2024 Jan 2;21(1):1. doi: 10.1186/s12986-023-00775-8. Nutr Metab (Lond). 2024. PMID: 38169398 Free PMC article.
-
Chronic Inflammation-A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue.Medicina (Kaunas). 2022 May 6;58(5):641. doi: 10.3390/medicina58050641. Medicina (Kaunas). 2022. PMID: 35630058 Free PMC article. Review.
References
-
- Federico A., Dallio M., Masarone M., Persico M., Loguercio C. The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: Role of endothelial dysfunction. Eur. Rev. Med. Pharmacol. Sci. 2016;20:4731–4741. - PubMed
-
- Lazo M., Hernaez R., Eberhardt M.S., Bonekamp S., Kamel I., Guallar E., Koteish A., Brancati F.L., Clark J.M. Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994. Am. J. Epidemiol. 2013;178:38–45. doi: 10.1093/aje/kws448. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical